| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pleurisy | D010998 | 20 associated lipids |
| Parkinsonian Disorders | D020734 | 20 associated lipids |
| Translocation, Genetic | D014178 | 20 associated lipids |
| Sarcoma 180 | D012510 | 21 associated lipids |
| Myocardial Infarction | D009203 | 21 associated lipids |
| Helicobacter Infections | D016481 | 21 associated lipids |
| Carcinoma, Lewis Lung | D018827 | 22 associated lipids |
| Hyperlipoproteinemia Type II | D006938 | 22 associated lipids |
| Hypersensitivity | D006967 | 22 associated lipids |
| Erythema | D004890 | 22 associated lipids |
PGD2
Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.
Cross Reference
Introduction
To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with PGD2?
PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with PGD2
PubChem Associated disorders and diseases
What pathways are associated with PGD2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with PGD2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with PGD2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with PGD2?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with PGD2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with PGD2?
Knock-out
Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).
Rodent Model
Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with PGD2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Matsushima Y et al. | Distinct roles of prostaglandin D2 receptors in chronic skin inflammation. | 2011 | Mol. Immunol. | pmid:21943706 |
| Papageorgiou E et al. | Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells. | 2008 Jul-Aug | Mol. Med. | pmid:18475308 |
| Ashby B | Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets. | 1990 | Mol. Pharmacol. | pmid:1695318 |
| Sykes DA et al. | Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy. | 2016 | Mol. Pharmacol. | pmid:26916831 |
| Tanaka Y et al. | Hepatic ischemia-reperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice. | 2007 | Mol. Pharmacol. | pmid:17151289 |
| Yagami T et al. | Human group IIA secretory phospholipase A2 induces neuronal cell death via apoptosis. | 2002 | Mol. Pharmacol. | pmid:11752212 |
| Hata AN et al. | Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2. | 2005 | Mol. Pharmacol. | pmid:15563582 |
| Katura T et al. | 15-Deoxy-delta 12,14-prostaglandin J2 biphasically regulates the proliferation of mouse hippocampal neural progenitor cells by modulating the redox state. | 2010 | Mol. Pharmacol. | pmid:20086036 |
| Mathiesen JM et al. | On the mechanism of interaction of potent surmountable and insurmountable antagonists with the prostaglandin D2 receptor CRTH2. | 2006 | Mol. Pharmacol. | pmid:16418339 |
| Lee SJ et al. | Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation. | 2006 | Mol. Pharmacol. | pmid:16611854 |
| Rockwell CE et al. | Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. | 2006 | Mol. Pharmacol. | pmid:16611855 |
| Zhao G et al. | Pivotal role of reactive oxygen species in differential regulation of lipopolysaccharide-induced prostaglandins production in macrophages. | 2013 | Mol. Pharmacol. | pmid:23071105 |
| Raman P et al. | 15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma. | 2011 | Mol. Pharmacol. | pmid:21511917 |
| Savinainen JR et al. | Robust hydrolysis of prostaglandin glycerol esters by human monoacylglycerol lipase (MAGL). | 2014 | Mol. Pharmacol. | pmid:25140003 |
| Miwa Y et al. | 15-Deoxy-Delta(12,14)-prostaglandin J(2) induces G(1) arrest and differentiation marker expression in vascular smooth muscle cells. | 2000 | Mol. Pharmacol. | pmid:10999955 |
| Cuzzocrea S et al. | The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation. | 2002 | Mol. Pharmacol. | pmid:11961117 |
| Chen ZY and Tseng CC | 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells. | 2005 | Mol. Pharmacol. | pmid:16077033 |
| Mix KS et al. | Peroxisome proliferator-activated receptor-gamma-independent repression of collagenase gene expression by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and prostaglandin 15-deoxy-delta(12,14) J2: a role for Smad signaling. | 2004 | Mol. Pharmacol. | pmid:14742672 |
| Ianaro A et al. | Anti-inflammatory activity of 15-deoxy-delta12,14-PGJ2 and 2-cyclopenten-1-one: role of the heat shock response. | 2003 | Mol. Pharmacol. | pmid:12815164 |
| Chung SW et al. | Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor. | 2003 | Mol. Pharmacol. | pmid:14573767 |
| Fionda C et al. | Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes. | 2007 | Mol. Pharmacol. | pmid:17673570 |
| Stillman BA et al. | Importance of the extracellular domain for prostaglandin EP(2) receptor function. | 1999 | Mol. Pharmacol. | pmid:10462542 |
| Ciucci A et al. | Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway. | 2006 | Mol. Pharmacol. | pmid:16908599 |
| Sánchez-Gómez FJ et al. | Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. | 2004 | Mol. Pharmacol. | pmid:15317873 |
| Jung KM et al. | Activation of p38 mitogen-activated protein kinase and activator protein-1 during the promotion of neurite extension of PC-12 cells by 15-deoxy-delta12,14-prostaglandin J2. | 2003 | Mol. Pharmacol. | pmid:12606768 |
| Berry EB et al. | Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B. | 2005 | Mol. Pharmacol. | pmid:15821150 |
| Bai YJ et al. | A LC-MS-based method for quantification of biomarkers from serum of allergic rats. | 2010 | Molecules | pmid:20657485 |
| Wojno ED et al. | The prostaglandin Dâ‚‚ receptor CRTH2 regulates accumulation of group 2 innate lymphoid cells in the inflamed lung. | 2015 | Mucosal Immunol | pmid:25850654 |
| Satoh K et al. | Lipid peroxidation end products-responded induction of a preneoplastic marker enzyme glutathione S-transferase P-form (GST-P) in rat liver on admistration via the portal vein. | 2001 | Mutat. Res. | pmid:11600134 |
| Poynard T et al. | Secretory diarrhea and prostaglandin D2 overproduction in systemic mastocytosis. | 1982 | N. Engl. J. Med. | pmid:6953312 |
| Laidlaw TM and Boyce JA | Aspirin-Exacerbated Respiratory Disease--New Prime Suspects. | 2016 | N. Engl. J. Med. | pmid:26840139 |
| Knapp HR | Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. | 1990 | N. Engl. J. Med. | pmid:1701029 |
| Forman MB et al. | Increased adventitial mast cells in a patient with coronary spasm. | 1985 | N. Engl. J. Med. | pmid:2413358 |
| Goetzl EJ | Asthma: new mediators and old problems. | 1984 | N. Engl. J. Med. | pmid:6330554 |
| Naclerio RM et al. | Inflammatory mediators in late antigen-induced rhinitis. | 1985 | N. Engl. J. Med. | pmid:2582257 |
| Murray JJ et al. | Release of prostaglandin D2 into human airways during acute antigen challenge. | 1986 | N. Engl. J. Med. | pmid:3462506 |
| Wingard CJ et al. | Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation. | 2011 | Nanotoxicology | pmid:21043986 |
| Pettipher R et al. | Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. | 2007 | Nat Rev Drug Discov | pmid:17396136 |
| Taketomi Y et al. | Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis. | 2013 | Nat. Immunol. | pmid:23624557 |
| Starkl P et al. | PLA2G3 promotes mast cell maturation and function. | 2013 | Nat. Immunol. | pmid:23685814 |
| Gilroy DW et al. | Inducible cyclooxygenase may have anti-inflammatory properties. | 1999 | Nat. Med. | pmid:10371510 |
| Wang C et al. | A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles. | 2014 | Nat. Methods | pmid:24292485 |
| Luster AD and Tager AM | T-cell trafficking in asthma: lipid mediators grease the way. | 2004 | Nat. Rev. Immunol. | pmid:15343370 |
| Ricote M et al. | The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. | 1998 | Nature | pmid:9422508 |
| Jiang C et al. | PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. | 1998 | Nature | pmid:9422509 |
| Rossi A et al. | Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. | 2000 | Nature | pmid:10638762 |
| Wang JP et al. | Anti-inflammatory and analgesic effects of magnolol. | 1992 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:1336574 |
| Molderings GJ et al. | Modulation of noradrenaline release from the sympathetic nerves of human right atrial appendages by presynaptic EP3- and DP-receptors. | 1998 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:9826066 |
| Featherstone RL et al. | Evidence for thromboxane receptor mediated contraction of guinea-pig and human airways in vitro by prostaglandin (PG) D2, 9 alpha,11 beta-PGF2 and PGF2 alpha. | 1990 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:2142256 |
| Hsu MF et al. | Inhibition of the arachidonic acid cascade by norathyriol via blockade of cyclooxygenase and lipoxygenase activity in neutrophils. | 2004 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:15083266 |
| Prakash J et al. | Albumin-binding and tumor vasculature determine the antitumor effect of 15-deoxy-Delta-(12,14)-prostaglandin-J(2) in vivo. | 2009 | Neoplasia | pmid:20019843 |
| Lee S et al. | Rosiglitazone ameliorates cisplatin-induced renal injury in mice. | 2006 | Nephrol. Dial. Transplant. | pmid:16728429 |
| Li X et al. | Hypoxia reduces the expression and anti-inflammatory effects of peroxisome proliferator-activated receptor-gamma in human proximal renal tubular cells. | 2007 | Nephrol. Dial. Transplant. | pmid:17255125 |
| Panzer U et al. | 15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells. | 2008 | Nephrol. Dial. Transplant. | pmid:18596134 |
| Kimura H et al. | A natural PPAR-gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions. | 2008 | Nephrol. Dial. Transplant. | pmid:18367541 |
| Lu Y et al. | 15-Deoxy-Δ(12,14)-prostaglandin J(2) modulates lipopolysaccharide-induced chemokine expression by blocking nuclear factor-κB activation via peroxisome proliferator activated receptor-γ-independent mechanism in renal tubular epithelial cells. | 2013 | Nephron Exp. Nephrol. | pmid:23887394 |
| Kootte AM et al. | The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production. | 1983 | Neth J Med | pmid:6572798 |
| Flores JJ et al. | PPARγ-induced upregulation of CD36 enhances hematoma resolution and attenuates long-term neurological deficits after germinal matrix hemorrhage in neonatal rats. | 2016 | Neurobiol. Dis. | pmid:26739391 |
| Ogburn KD et al. | Prostaglandin J2 reduces catechol-O-methyltransferase activity and enhances dopamine toxicity in neuronal cells. | 2006 | Neurobiol. Dis. | pmid:16406650 |
| Liu H et al. | Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury. | 2011 | Neurobiol. Dis. | pmid:20933087 |
| Naffah-Mazzacoratti MG et al. | Profile of prostaglandin levels in the rat hippocampus in pilocarpine model of epilepsy. | 1995 | Neurochem. Int. | pmid:8574174 |
| Cho WH et al. | 15-deoxy-(Delta12,14)-prostaglandin J2 (15d-PGJ2) induces cell death through caspase-independent mechanism in A172 human glioma cells. | 2006 | Neurochem. Res. | pmid:17006759 |
| Gotoh M et al. | Desensitization of prostaglandin F2 alpha receptor-mediated phosphoinositide hydrolysis in cultured rat astrocytes. | 1994 | Neurochem. Res. | pmid:8065525 |
| Tsuji T et al. | Reduction of nuclear peroxisome proliferator-activated receptor gamma expression in methamphetamine-induced neurotoxicity and neuroprotective effects of ibuprofen. | 2009 | Neurochem. Res. | pmid:18946735 |
| Li W et al. | Neuronal cyclooxygenase-2 activity and prostaglandins PGE2, PGD2, and PGF2 alpha exacerbate hypoxic neuronal injury in neuron-enriched primary culture. | 2008 | Neurochem. Res. | pmid:17763946 |
| Urade Y et al. | Sleep regulation in adenosine A2A receptor-deficient mice. | 2003 | Neurology | pmid:14663019 |
| Dore-Duffy P et al. | Cerebrospinal fluid eicosanoid levels: endogenous PGD2 and LTC4 synthesis by antigen-presenting cells that migrate to the central nervous system. | 1991 | Neurology | pmid:1992386 |
| Kaneko K et al. | Novel orexigenic pathway prostaglandin D2-NPY system--involvement in orally active orexigenic δ opioid peptide. | 2012 | Neuropeptides | pmid:23141054 |
| Bate C et al. | Prostaglandin D2 mediates neuronal damage by amyloid-beta or prions which activates microglial cells. | 2006 | Neuropharmacology | pmid:16289250 |
| Grill M et al. | Systemic inflammation induces COX-2 mediated prostaglandin D2 biosynthesis in mice spinal cord. | 2006 | Neuropharmacology | pmid:16182321 |
| Costello DA et al. | Agonists of peroxisome proliferator-activated receptor-gamma attenuate the Abeta-mediated impairment of LTP in the hippocampus in vitro. | 2005 | Neuropharmacology | pmid:15993441 |
| Morgenweck J et al. | Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema. | 2010 | Neuropharmacology | pmid:19891980 |
| GarcÃa-Bueno B et al. | Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats. | 2007 | Neuropsychopharmacology | pmid:17119541 |
| Rohn TT et al. | 15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis. | 2001 | Neuroreport | pmid:11277593 |
| Yoshida Y et al. | Prostaglandin E (EP) receptor subtypes and sleep: promotion by EP4 and inhibition by EP1/EP2. | 2000 | Neuroreport | pmid:10923657 |
| Terao A et al. | Enhancement of slow-wave sleep by tumor necrosis factor-alpha is mediated by cyclooxygenase-2 in rats. | 1998 | Neuroreport | pmid:9875706 |
| Horváth B et al. | Carbon monoxide-prostaglandin E2 interaction in the hypothalamic circulation. | 2008 | Neuroreport | pmid:18815586 |
| Govoni S et al. | The Cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. | 2001 | Neurosci. Lett. | pmid:11311500 |
| Leamy AW et al. | Curcumin ((E,E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) activates and desensitizes the nociceptor ion channel TRPA1. | 2011 | Neurosci. Lett. | pmid:21855605 |
| Nakae K et al. | Functional role of prostacyclin receptor in rat dorsal root ganglion neurons. | 2005 | Neurosci. Lett. | pmid:16039053 |
| Wu L et al. | Divergent effects of prostaglandin receptor signaling on neuronal survival. | 2007 | Neurosci. Lett. | pmid:17574754 |
| Kitamura Y et al. | Activators of peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells. | 1999 | Neurosci. Lett. | pmid:10203248 |
| Marchini C et al. | Aspirin modulates LPS-induced nitric oxide release in rat glial cells. | 2005 Jun 10-17 | Neurosci. Lett. | pmid:15882795 |
| Ott D et al. | Prostaglandin D2 modulates calcium signals induced by prostaglandin E2 in neurons of rat dorsal root ganglia. | 2015 | Neurosci. Lett. | pmid:25912777 |
| Myeku N et al. | cAMP stimulates the ubiquitin/proteasome pathway in rat spinal cord neurons. | 2012 | Neurosci. Lett. | pmid:22982149 |
| Inoué S et al. | Little sleep-promoting effect of three sleep substances diurnally infused in unrestrained rats. | 1984 | Neurosci. Lett. | pmid:6593603 |
| Satoh S et al. | Promotion of sleep by prostaglandin D2 in rats made insomniac by pretreatment with para-chlorophenylalanine. | 1994 | Neurosci. Res. | pmid:7708292 |
| Osaka T and Hayaishi O | Prostaglandin D2 modulates sleep-related and noradrenaline-induced activity of preoptic and basal forebrain neurons in the rat. | 1995 | Neurosci. Res. | pmid:8545074 |
| Vesin MF et al. | Biosynthesis of prostaglandin D2 by motoneurons and dorsal horn microneurons: a biochemical and high resolution immunocytochemical study in chick spinal cord. | 1995 | Neuroscience | pmid:8596663 |
| Liu M et al. | Focal cerebral ischemia/reperfusion injury in mice induces hematopoietic prostaglandin D synthase in microglia and macrophages. | 2007 | Neuroscience | pmid:17241746 |
| Telleria-Diaz A et al. | Different effects of spinally applied prostaglandin D2 on responses of dorsal horn neurons with knee input in normal rats and in rats with acute knee inflammation. | 2008 | Neuroscience | pmid:18678231 |
| Zurich MG et al. | Unusual astrocyte reactivity caused by the food mycotoxin ochratoxin A in aggregating rat brain cell cultures. | 2005 | Neuroscience | pmid:15994020 |
| Pena-dos-Santos DR et al. | Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint. | 2009 | Neuroscience | pmid:19647045 |
| Horiguchi T et al. | Cyclooxygenase-2 mediates the development of cortical spreading depression-induced tolerance to transient focal cerebral ischemia in rats. | 2006 | Neuroscience | pmid:16567054 |
| Hayaishi O and Urade Y | Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives. | 2002 | Neuroscientist | pmid:11843094 |
| Shohami E et al. | Experimental closed head injury in rats: prostaglandin production in a noninjured zone. | 1988 | Neurosurgery | pmid:3164097 |
| Liu H et al. | Prostaglandin D2 toxicity in primary neurons is mediated through its bioactive cyclopentenone metabolites. | 2013 | Neurotoxicology | pmid:23973622 |
| Toscano CD et al. | NMDA-induced seizure intensity is enhanced in COX-2 deficient mice. | 2008 | Neurotoxicology | pmid:18834901 |
| Sakai T | [Molecular cancer epidemiology--the present status and future possibilities]. | 1996 | Nihon Eiseigaku Zasshi | pmid:8720930 |
| Nishimura G | [Antitumor activity and cell cycle effects of delta 12-PGJ2 in vivo]. | 1990 | Nihon Gan Chiryo Gakkai Shi | pmid:2351856 |